In this interview with Tony Veverka, Chief Group Executive of BioEden, Mr. Veverka discusses how dental stem cells will impact our future. BioEden is a global stem cell storage company with laboratories in the UK and USA and sales operations in 19 countries. BioEden is also the world’s first international biobank company to collect, assess, and cryogenically store living stem cells from deciduous baby teeth.
Dental pulp is the soft living tissue inside a tooth that contains mesenchymal stem cells (MSCs). The ideal time to harvest dental stem cells is when children lose their deciduous (baby) teeth, either through natural loss or extraction.
An important way to gauge innovation and progress within the dental stem cell market is to consider trend rate data for scientific publications over a trailing ten-year period.
Analysis of Scientific Publication Data
PubMed is a service of the U.S. National Library of Medicine and the National Institutes of Health (NIH) that contains citations from MEDLINE and a collection of other life science journals.
The data presented below was generated using the PubMed database, because it is the largest, most comprehensive, and most up-to-date resource aggregating scientific publications worldwide.
It is also the most versatile tool for screening by multiple criteria. [Read more…]
As 2016 approaches, it is an important time to look back on 2015 and all that the year entailed for stem cell advances. During 2016, I was honored to have interviewed a number of key thought leaders in the stem cell space, including the CEO of the largest dental stem cell company in the world (Tony Veverka of BioEden), Chief Business Officer for a company creating the world’s largest blood cell repository for iPSC production (James Lovgren of ORIG3N), and VP of Research and Development for one of the most innovative companies operating within the stem cell sector (Dr. Grynspan of Stem Cell Medicine).
Throughout 2015, my team and I conducted dozens of other interviews as well, with stem cell executives, investors, and researchers. These interviews were published on our stem cell industry blog and also informed market projections for BioInformant’s stem cell and cord blood market intelligence reports. [Read more…]
Dental pulp is the soft living tissue inside a tooth that contains mesenchymal stem cells (MSCs). While MSCs from dental pulp stem cells are only being used only in laboratory settings right now, there are now a handful of forward-thinking companies that offer dental stem cell storage services to preserve the cells for future regenerative use.
The dental pulp storage market is still relatively small, because of the early stage of research concerning the use of dental pulp stem cells in humans. However, it is rapidly expanding on a global basis, with 1-2 new dental storage providers are entering the market every month, based on a trailing 12-month history (January to December, 2015).
BioEden began offering tooth stem cell storage as early as 2006, making it one of the earliest known providers of dental stem cell storage. Over the past decade, the company has continued to be one of the most dominant competitors in this space, controlling an estimated 45% of current market share within the dental stem cell storage market. Click here to learn more about the dental stem cell banking market or to read our recent interview with BioEden’s CEO, Tony Veverka. [Read more…]